Bloomberg Technology
Mammoth Bio CEO on Bayer Pact to Make Crispr Therapies
Mammoth Biosciences CEO Trevor Martin joins Emily Chang to discuss the company’s latest partnership with Bayer to develop therapies and fortify its cell and gene therapy platform.
Sir Derty ✓
January 11, 2022 at 12:30 am
They never talk about the síde effects and cons of lab testing innovations like this.. i hope its all good but we know it is making new dna, and life form dna… so, be honest please with this new tech.
Jonathan Delk
January 11, 2022 at 12:40 am
If I had a life threatening disease that could be cured, I am doing this if it gives me a longer life span. wish more people funded research like this instead of soy chicken nuggets, and delicious sodas. ethically speaking, short life span seems like life cruelest joke.
Brashawn Williams
January 11, 2022 at 12:35 am
This is a revelation of how the universe was populated with life.